Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
UNITED BANCORP INC /OH/United Bancorp Reports $828.1 Million in Total Assets for Fiscal Year 2025
BEST BUY CO INCBest Buy Reports Modest Revenue Increase to $41.7 Billion in Fiscal 2026
Moleculin Biotech, Inc.Moleculin Biotech Reports $33.6 Million Net Loss for 2025, Advances Annamycin in Phase 3 Trial
Processa Pharmaceuticals, Inc.Processa Pharmaceuticals Reports $13.6 Million Net Loss for Fiscal Year 2025
Bitcoin Depot Inc.Bitcoin Depot Reports $614.9 Million Revenue for 2025, Faces Regulatory Challenges
DOCUSIGN, INC.DocuSign Reports $3.22 Billion Revenue with 8% Growth for Fiscal Year Ending January 31, 2026
SERA PROGNOSTICS, INC.Sera Prognostics Reports Fiscal Year 2025 Results with Revenue Increase and Net Loss
Usio, Inc.Usio, Inc. Reports 3% Revenue Increase to $85.4 Million, Net Loss of $2.5 Million for Fiscal Year 2025
GENERAL MILLS INCGeneral Mills Reports Decline in Q3 Financial Performance, Net Sales Down 8%
Envela CorpEnvela Corporation Reports 33.6% Revenue Growth to $241M in Fiscal Year 2025
PROKIDNEY CORP.ProKidney Corp. Reports Fiscal Year 2025 Results and Focus on Rilparencel Development
INNOVATIVE DESIGNS INCInnovative Designs Reports 16.2% Revenue Growth and 346.5% Increase in Net Income
Lifeward Ltd.Lifeward Ltd. Reports 14% Revenue Decline for Fiscal Year 2025
PEOPLES FINANCIAL CORP /MS/Peoples Financial Corporation Reports Significant Decline in Net Income for Fiscal Year 2025
Mastech Digital, Inc.Mastech Digital Reports $191.4 Million Revenue for Fiscal Year 2025, 3.8% Decline
Neonode Inc.Neonode Inc. Reports $8M Net Income Turnaround Driven by Patent Assignment
InspireMD, Inc.InspireMD Reports 28.1% Revenue Growth to $8.98 Million for Fiscal Year 2025
GIFTIFY, INC.Giftify, Inc. Reports $10.5 Million Net Loss, Acquires CardCash and Takeout7
Cingulate Inc.Cingulate Inc. Reports $22.4 Million Net Loss for Fiscal Year 2025 Amid Rising Expenses
Protalix BioTherapeutics, Inc.Protalix BioTherapeutics Reports $52.7 Million Revenue for Fiscal Year 2025
Estrella Immunopharma, Inc.Estrella Immunopharma Reports $13.1 Million Net Loss and Increased R&D Expenses for 2025
Vyome Holdings, IncVyome Holdings Reports Revenue Growth and Increased Operating Expenses Following Merger
PGIM Private Credit FundPGIM Private Credit Fund Reports $28.8M Investment Income for 2025
dMY Squared Technology Group, Inc.dMY Squared Technology Group Reports $17.8 Million Net Loss for Fiscal Year 2025
CENTURY CASINOS INC /CO/Century Casinos Reports Slight Revenue Increase and Strategic Acquisitions for Fiscal Year 2025